ADB-Butinaca (N-(1-Adamantyl)-1-(But-3-yn-1-yl)-1H-Indazole-3-Carboxamide)
High-Purity Synthetic Cannabinoid for Advanced Laboratory Research
ADB-Butinaca, also known as ADB-BUTINACA, is a synthetic cannabinoid of the indazole-3-carboxamide class — developed for scientific and pharmacological research into cannabinoid receptor activation and signaling pathways. It acts as a potent agonist at CB1 and CB2 receptors, making it a valuable tool for exploring the endocannabinoid systemand the neurochemical processes it regulates.
Scientific Overview
Researchers utilize ADB-Butinaca to investigate:
Receptor binding affinities (CB1/CB2)
⚙️ Pharmacodynamics of synthetic cannabinoids
Neurotransmitter modulation
Structure-activity relationships (SAR)
Its selective receptor activity provides a reliable foundation for controlled studies into neurological response, behavioral pharmacology, and therapeutic potential modeling of cannabinoid-type compounds.
⚠️ Safety & Handling Notice
ADB-Butinaca is a highly potent research compound with limited toxicological and long-term safety data. It must only be handled by qualified professionals in certified laboratory environments under strict safety procedures.
Potential Risks Include:
❗ Central nervous system overstimulation or dysregulation
❗ Cardiovascular strain and unpredictable receptor response
❗ Unknown metabolic and toxicological pathways
STRICTLY FOR RESEARCH USE ONLY
-
Not for human or animal consumption
-
Not for medical, therapeutic, or recreational use
-
Use only within legal, ethical, and controlled research settings
All experiments must comply with GLP standards, chemical handling regulations, and bioethics guidelines.
Key Features
✅ Analytical-grade purity for reproducible lab results
✅ Valuable for cannabinoid receptor and SAR studies
✅ Suitable for forensic, toxicological, and neurochemical research
ADB-Butinaca serves as a critical tool for scientists advancing our understanding of synthetic cannabinoid pharmacology and receptor-targeted neurochemistry. ⚗️
